✦ LIBER ✦

BU and CY as conditioning regimen for autologous transplant in patients with multiple myeloma

✍ Scribed by Talamo, G; Claxton, D F; Dougherty, D W; Ehmann, C W; Sivik, J; Drabick, J J; Rybka, W

Book ID: 109840615
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 204 KB
Volume: 44
Category: Article
ISSN: 0007-1188
DOI: 10.1038/bmt.2008.446

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Busulfan and melphalan as conditioning r

Busulfan and melphalan as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma

✍ A. Alegre; M. Lamana; R. Arranz; M. J. Fernández-Villalta; J. F. Tomás; A. Figue 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB

Unrelated Cord Blood Transplantation wit

✍ Toshiki Yamada; Akira Tomonari; Satoshi Takahashi; Jun Ooi; Tohru Iseki; Yoko Sh 📂 Article 📅 2004 🏛 Carden Jennings Publishing 🌐 English ⚖ 64 KB

Busulfan and cyclophosphamide (BU/CY2) a

Busulfan and cyclophosphamide (BU/CY2) as preparative regimen for patients with lymphoma

✍ deMagalhaes-Silverman, M; Lister, J; Rybka, W; Wilson, J; Ball, E 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

Continuous Infusion Cyclophosphamide and

Continuous Infusion Cyclophosphamide and Low Dose Total Body Irradiation (CICy/ldTBI) As a Conditioning Regimen for Tandem Autologous Transplant in Multiple Myeloma

✍ Byrne, Michael; Leather, Helen; Wingard, John R.; Moreb, Jan 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Busulfan and Cyclophosphamide (Bu/Cy) as

Busulfan and Cyclophosphamide (Bu/Cy) as a Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma: A Single-Institution Experience

✍ Matthew Ulrickson; Julie Aldridge; Haesook T. Kim; Ephraim P. Hochberg; Peter Ha 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 221 KB

Busulfan, cyclophosphamide, and etoposid

Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma

✍ Christopher R. Cogle; Jan S. Moreb; Helen L. Leather; Katarzyna J. Finiewicz; Sh 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Abstract Autologous stem cell transplantation (ASCT) has enabled the use of high‐dose alkylating agents either as a single agent or in combination with other cytotoxic agents and/or total body irradiation (TBI) for the treatment of multiple myeloma. Despite improved complete remission rates, rel